Prescription drug · ANDA
Terbinafine NDC 76282-209
Terbinafine hydrochloride 250 mg/1 · Tablet · Oral · Exelan Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 76282-209-01 | 7628202090176282020901 | 100 TABLET in 1 BOTTLE (76282-209-01)Marketed from Apr 25, 2012 | |
| 76282-209-05 | 7628202090576282020905 | 500 TABLET in 1 BOTTLE (76282-209-05)Marketed from Apr 25, 2012 | |
| 76282-209-30 | 7628202093076282020930 | 30 TABLET in 1 BOTTLE (76282-209-30)Marketed from Apr 25, 2012 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Terbinafine
- Generic name (nonproprietary)
- terbinafine
- Active ingredients
- Terbinafine hydrochloride — 250 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Exelan Pharmaceuticals Inc.NDC labeler code 76282
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077533
- Marketing start
- Listing expires
- Other FDA classes
- Allylamine (Chemical structure)
- Identifiers
- Product ID 76282-209_dc86cdd6-0a8a-4e5c-b3c4-8b05388af862SPL ID dc86cdd6-0a8a-4e5c-b3c4-8b05388af862SPL set ID 6dc279cc-9861-4fa8-8083-ca3b3c57b513RxCUI 313222UNII 012C11ZU6GUPC 0376282209302
- Pharmacologic class
- Allylamine Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N476282020901followed by a unit qualifier and the quantityPackage 76282-0209-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Terbinafine tablets, USP are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis. Terbinafine tablets are an allylamine antifungal indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium).
Excerpt only. Read the full label for complete information.
About NDC 76282-209
- What is NDC 76282-209?
- 76282-209 is the product NDC for Terbinafine, Terbinafine hydrochloride 250 mg/1 tablet, listed with the FDA by Exelan Pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Terbinafine.
- What is the active ingredient?
- Terbinafine hydrochloride.
- Who is the labeler?
- Exelan Pharmaceuticals Inc., NDC labeler code 76282. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Terbinafine?
- 19 other product NDCs are listed under this name. See all Terbinafine NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Terbinafine products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Terbinafineterbinafine hydrochloride tablet | Terbinafine hydrochloride 250 mg/1 | TabletOral | Amerisyn LLC | 87564-010 | 87564-0010-1087564-0010-30 |
| Terbinafineterbinafine hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | American Health Packaging | 60687-909 | 60687-0909-21 |
| Terbinafine | Terbinafine hydrochloride 250 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4421 | 70518-4421-0070518-4421-0170518-4421-02+1 more |
| Terbinafine | Terbinafine hydrochloride 250 mg/1 | TabletOral | direct rx | 72189-243 | 72189-0243-30 |
| Terbinafineterbinafine hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-2941 | 70518-2941-00 |
| Terbinafine | Terbinafine hydrochloride 250 mg/1 | TabletOral | Cipla USA Inc. | 69097-859 | 69097-0859-0269097-0859-0769097-0859-12 |
| Terbinafine | Terbinafine hydrochloride 250 1/1 | TabletOral | Proficient Rx LP | 71205-152 | 71205-0152-1571205-0152-3071205-0152-35+3 more |
| Terbinafineterbinafine hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | NorthStar Rx LLC | 16714-795 | 16714-0795-0116714-0795-02 |
| Terbinafineterbinafine hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | A-S Medication Solutions | 50090-3575 | 50090-3575-0050090-3575-01 |
| Terbinafineterbinafine hydrochloride | Terbinafine hydrochloride 250 mg/1 | TabletOral | A-S Medication Solutions | 50090-3654 | 50090-3654-0050090-3654-01 |
Other NDCs under ANDA 077533
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Terbinafine | Terbinafine hydrochloride 250 mg/1 | TabletOral | Cipla USA Inc. | 69097-859 |
| Terbinafine | Terbinafine hydrochloride 250 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4421 |
| Terbinafine | Terbinafine hydrochloride 250 1/1 | TabletOral | Proficient Rx LP | 71205-152 |